全文获取类型
收费全文 | 253篇 |
免费 | 16篇 |
出版年
2023年 | 8篇 |
2022年 | 7篇 |
2021年 | 11篇 |
2020年 | 4篇 |
2019年 | 8篇 |
2018年 | 14篇 |
2017年 | 17篇 |
2016年 | 20篇 |
2015年 | 12篇 |
2014年 | 12篇 |
2013年 | 19篇 |
2012年 | 19篇 |
2011年 | 14篇 |
2010年 | 11篇 |
2009年 | 7篇 |
2008年 | 10篇 |
2007年 | 15篇 |
2006年 | 16篇 |
2005年 | 13篇 |
2004年 | 9篇 |
2003年 | 4篇 |
2002年 | 7篇 |
2001年 | 2篇 |
1999年 | 1篇 |
1997年 | 1篇 |
1995年 | 1篇 |
1991年 | 2篇 |
1989年 | 1篇 |
1982年 | 1篇 |
1891年 | 2篇 |
1889年 | 1篇 |
排序方式: 共有269条查询结果,搜索用时 46 毫秒
11.
Ramazan Ulus İbrahim Yeşildağ Muhammet Tanç Metin Bülbül Muharrem Kaya Claudiu T. Supuran 《Bioorganic & medicinal chemistry》2013,21(18):5799-5805
4-Amino-N-(4-sulfamoylphenyl)benzamide was synthesized by reduction of 4-nitro-N-(4-sulfamoylphenyl)benzamide and used to synthesize novel acridine sulfonamide compounds, by a coupling reaction with cyclic-1,3-diketones and aromatic aldehydes. The new compounds were investigated as inhibitors of the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1), and more precisely the cytosolic isoforms hCA I, II and VII. hCA I was inhibited in the micromolar range by the new compounds (KIs of 0.16–9.64 μM) whereas hCA II and VII showed higher affinity for these compounds, with KIs in the range of 15–96 nM for hCA II, and of 4–498 nM for hCA VII. The structure–activity relationships for the inhibition of these isoforms with the acridine–sulfonamides reported here were also elucidated. 相似文献
12.
Kadir Aksu Meryem Nar Muhammet Tanc Daniela Vullo İlhami Gülçin Süleyman Göksu Ferhan Tümer Claudiu T. Supuran 《Bioorganic & medicinal chemistry》2013,21(11):2925-2931
A series of novel sulfamides incorporating the dopamine scaffold were synthesized. Reaction of amines and tert-butyl-alcohol/benzyl alcohol in the presence of chlorosulfonyl isocyanate (CSI) afforded sulfamoyl carbamates, which were converted to the title compounds by treatment with trifluoroacetic acid or by palladium-catalyzed hydrogenolysis. Inhibition of six α-carbonic anhydrases (CAs, EC 4.2.1.1), that is, CA I, CA II, CA VA, CA IX, CA XII and CA XIV, and two β-CAs from Candida glabrata (CgCA) and Mycobacterium tuberculosis (Rv3588) with these sulfamides was investigated. All CA isozymes were inhibited in the low micromolar to nanomolar range by the dopamine sulfamide analogues. Kis were in the range of 0.061–1.822 μM for CA I, 1.47–2.94 nM for CA II, 2.25–3.34 μM for CA VA, 0.041–0.37 μM for CA IX, 0.021–1.52 μM for CA XII, 0.007–0.219 μM for CA XIV, 0.35–5.31 μM for CgCA and 0.465–4.29 μM for Rv3588. The synthesized sulfamides may lead to inhibitors targeting medicinally relevant CA isoforms with potential applications as antiepileptic, antiobesity antitumor agents or anti-infective. 相似文献
13.
14.
Kurosh Ameri Anthony M. Rajah Vien Nguyen Timothy A. Sanders Arman Jahangiri Michael DeLay Matthew Donne Hwa J. Choi Kathryn V. Tormos Yerem Yeghiazarians Stefanie S. Jeffrey Paolo F. Rinaudo David H. Rowitch Manish Aghi Emin Maltepe 《PloS one》2013,8(4)
Cellular stress responses are frequently governed by the subcellular localization of critical effector proteins. Apoptosis-inducing Factor (AIF) or Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH), for example, can translocate from mitochondria to the nucleus, where they modulate apoptotic death pathways. Hypoxia-inducible gene domain 1A (HIGD1A) is a mitochondrial protein regulated by Hypoxia-inducible Factor-1α (HIF1α). Here we show that while HIGD1A resides in mitochondria during physiological hypoxia, severe metabolic stress, such as glucose starvation coupled with hypoxia, in addition to DNA damage induced by etoposide, triggers its nuclear accumulation. We show that nuclear localization of HIGD1A overlaps with that of AIF, and is dependent on the presence of BAX and BAK. Furthermore, we show that AIF and HIGD1A physically interact. Additionally, we demonstrate that nuclear HIGD1A is a potential marker of metabolic stress in vivo, frequently observed in diverse pathological states such as myocardial infarction, hypoxic-ischemic encephalopathy (HIE), and different types of cancer. In summary, we demonstrate a novel nuclear localization of HIGD1A that is commonly observed in human disease processes in vivo. 相似文献
15.
16.
17.
18.
F. Zehra Küçükbay Hasan Küçükbay Muhammet Tanc 《Journal of enzyme inhibition and medicinal chemistry》2016,31(6):1198-1202
N-Protected amino acids (Gly, Ala and Phe) were reacted with amino substituted coumarin and quinolinone derivatives, leading to the corresponding N-protected amino acid–coumarin/quinolinone conjugates. The carbonic anhydrase (CA, EC 4.2.1.1) inhibitory activity of the new compounds was assessed against various human (h) isoforms, such as hCA I, hCA II, hCA IV and hCA XII. The quinolinone conjugates were inactive as enzyme inhibitors, whereas the coumarins were ineffective hCA I/II inhibitors (KIs?>?50?μM) but were submicromolar hCA IV and XII inhibitors, with inhibition constants ranging between 92?nM and 1.19?μM for hCA IV, and between 0.11 and 0.79?μM for hCA XII. These coumarin derivatives, as many others reported earlier, thus show an interesting selective inhibitory profile for the membrane-bound over the cytosolic CA isoforms. 相似文献
19.
Halise Inci Gul Zehra Yazici Muhammet Tanc 《Journal of enzyme inhibition and medicinal chemistry》2016,31(6):1540-1544
New phenolic mono and bis Mannich bases incorporating benzimidazole, such as 2-(aminomethyl)-4-(1H-benzimidazol-2-yl)phenol and 2,6-bis(aminomethyl)-4-(1H-benzimidazol-2-yl)phenol were synthesized starting from 4-(1H-benzimidazol-2-yl)phenol. Amines used for the synthesis included dimethylamine, pyrrolidine, piperidine, N-methylpiperazine and morpholine. The CA inhibitory properties of these compounds were tested on the human carbonic anhydrase (CA, EC 4.2.1.1) isoforms hCA I and hCA II. These new compounds, as many phenols show moderate CA inhibitory properties. 相似文献
20.